Cysticercosis in epileptic patients of Mulungu do Morro Northeastern Brazil

Arquivos de Neuro-Psiquiatria

Volumn 58, Issue 3 A, 2000, Pages 621-624

  Gomes, Irenio ^b   Veiga, Marielza ^b   Correa, Dolores ^a   Meza Lucas, Antonio ^a   Mata, Olga ^a   Garcia, Roberto Carlos ^a   Osornio, Alejandro ^a   Rabelo, Rosângela ^b   Lucena, Rita ^b   Melo, Ailton ^b  

^a Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^b NONE

Author keywords

Cysticercosis; Epidemiology; Epilepsy; Neurocysticereosis; Seizures

Indexed keywords

HELMINTH ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; CYSTICERCOSIS; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HUMAN; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; PARASITOLOGY; POVERTY; PREVALENCE; WESTERN BLOTTING;

ADOLESCENT; ADULT; ANTIBODIES, HELMINTH; BLOTTING, WESTERN; BRAZIL; CHILD; CYSTICERCOSIS; ENDEMIC DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; POVERTY AREAS; PREVALENCE;

EID: 0034268675     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0004-282X2000000400004     Document Type: Article

References (17)

1. Davis LE, Kernfeld M. Neurocysticercosis: neurologic, pathogenic, diagnostic and therapeutic aspects. Eur Neurol 1991;5:229-240.
2. Takayanagni OM. Neurocysticercosis: I. Clinical and laboratory course of 151 cases. Arq Neuropsiquiatr 1990;48:1-10.
3. Arruda WO. Etiology of epilepsy: a prospective study of 210 cases. Arq Neuropsiquiatr 1991;49(3):251-254.
4. Agapejev S. Epidemiology of neurocysticercosis in Brazil. Rev Inst Med Trop São Paulo 1996; 38(3):207-216.
5. Tsang VCW, Brand JA, Boyer AE. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis. J Infect Dis 1989;159:50-59.
6. Aranda-Alvarez JG, Tapia Romero R, Alcántara-Anguiano Y, et al. Human cysticercosis: risk factors associated with seric antigens in an open community of San Luis Potosí, México. Ann Trop Med Parasitol 1995;89:689-692.
7. Garcia HH, Gilman RH, Tsang VC, Gonzalez AE. Clinical significance of neurocysticercosis in endemic village. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg 1997;91:176-178.
8. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990;150:325-327.
9. Spina-França A, Livramento JA, Bacheschi LA, Garcia-Lopes P. Cerbrospinal fluid immunoglobulins in cysticercosis of the central nervous system. Arq Neuropsiquiatr 1976;34:40-45.
10. Machado AB, Pialarissi CS, Vaz AJ. Human cysticercosis diagnosed at a general hospital, São Paulo SP. Rev Saude Publica 1988;22:240-244.
11. Gonçalves-Coelho TD, Coelho MD. Cerebral cysticercosis in Campina Grande, Paraíba-northern Brazil: computerized tomography diagnosis importance. Arq Neuropsiquiatr 1996;54:94-97.
12. Sousa AQ, Sa HL, Queiroz TR, Horta WG, Pearson RD. Neurocysticereosis in Ceara State, northeastern Brazil: a review of 119 cases. Am J Trop Med Hyg 1998;58:759-762.
13. Takayanagui OM, Jardim E. Clinical aspects of neurocysticercosis: analysis of 500 cases. Arq Neuropsiquiatr 1983;41:50-63.
14. De Albuquerque ES, Galhardo I. Neurocysticercosis in the State of Rio Grande do Norte: report of 8 cases. Arq Neuropsiquiatr 1995;53:464-470.
15. Trevisol-Bittencourt PC, da Silva NC, Figueredo R. Prevalence of neurocysticercosis among epileptic in-patients in the west of Santa Catarina, southern Brazil. Arq Neuropsiquiatr 1998;56:53-58.
16. Garcia HH, Matinez M, Gilman R, et al. Diagnosis of cysticercosis in endemic regions. Lancet 1991;338:549-551.
17. Schantz PM, Sarti E, Plancarte A, Wilson M, Criales JL, Flisser A. Community-based epidemiological investigations of cysticercosis due to Taenia solium: comparison of serological screening tests and clinical findings in two populations in Mexico. Clin Inf Dis 1994;18:879-895.